0 items / CHF0.00

<img src="https://legacypharmaceuticals.ch/wp-content/uploads/2022/02/legacy-pharmaceuticals-logo.png" alt="Legacy Pharmaceuticals" style="max-width: 180px;" />

<img src="https://legacypharmaceuticals.ch/wp-content/uploads/2022/02/legacy-pharmaceuticals-logo.png" alt="Legacy Pharmaceuticals" style="max-width: 180px;" />

0 items / CHF0.00

screenshot_2021-05-12_at_5.07.13_pm

Click to enlarge

Previous product

Danyelza (naxitamab-gqgk) CHF35,282.47

Back to products

Next product

<img width="600" height="600" src="https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/screenshot_2021-05-27_at_10.13.25_am-600x600.png" class="attachment-woocommerce_thumbnail size-woocommerce_thumbnail" alt="" srcset="https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/screenshot_2021-05-27_at_10.13.25_am-600x600.png 600w, https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/screenshot_2021-05-27_at_10.13.25_am-300x300.png 300w, https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/screenshot_2021-05-27_at_10.13.25_am-150x150.png 150w, https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/screenshot_2021-05-27_at_10.13.25_am.png 700w" sizes="(max-width: 600px) 100vw, 600px" />

Elzonris (tagraxofusp-erzs) CHF34,243.95

Padcev (enfortumab vedotin-ejfv)

CHF5,350.80

Padcev (enfortumab vedotin-ejfv) is a medication used for the 2nd-line treatment of adults with bladder cancer and cancers of the urinary tract.

Add to wishlist

Category: Oncology

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Padcev (enfortumab vedotin-ejfv)”

Start typing to see products you are looking for.

No account yet?

Create an Account